Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Completed 4Terminated 2

Sponsor Class

OTHER 2NIH 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Lymphoid 6Other hematologic neoplasm 5Thoracic 4Genitourinary 4Plasma cell 2Gynecologic 2Gastrointestinal 2CNS 2Breast 2Other solid neoplasm 1Myeloid 1Dermatologic 1

Conditions

Lung Neoplasms 3Small Cell Lung Carcinoma 2Thoracic Neoplasms 1Prostatic Neoplasms 1Cardiotoxicity 1Carcinoma, Transitional Cell 1Carcinoma, Small Cell 1Breast Neoplasms 1Atrial Fibrillation 1

Interventions

Carboplatin 463Cisplatin 379Paclitaxel 313Pemetrexed 300Docetaxel 242Erlotinib Hydrochloride 240Gemcitabine 232pembrolizumab 173Radiotherapy 172Bevacizumab 169Nivolumab 130Etoposide 106Gefitinib 95Vinorelbine 84durvalumab 71atezolizumab 68Cetuximab 65Topotecan 61Drug Therapy 57Ipilimumab 55Irinotecan 54osimertinib 53Radiosurgery 52Afatinib 51Surveys and Questionnaires 38130-nm albumin-bound paclitaxel 38Albumin-Bound Paclitaxel 37Taxes 35Cyclophosphamide 35Surgical Procedures, Operative 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Electrocardiography × Thoracic × Clear all
NCT02769962 2025-07-28

Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
45 enrolled 30 charts
GenitourinaryThoracic

Carcinoma, Transitional Cell, Lung Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT03554473 2025-05-09

M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
37 enrolled 19 charts
Thoracic

Lung Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT03396614 2024-02-28

CROSS SECT

University Medical Center Groningen

Completed
40 enrolled
Thoracic

Thoracic Neoplasms

NCT05927246 2023-07-03

RADAF

Istanbul University

Completed
400 enrolled
BreastThoracic

Atrial Fibrillation, Breast Neoplasms, Lung Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡